US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Artelo Biosciences, Inc.

4.18

-0.6700-13.81%

Volume:1.66M

Turnover:5.80M

Market Cap:9.94M

PE:-0.11

High:4.51

Open:2.96

Low:2.96

Close:4.85

52wk High:85.80

52wk Low:2.96

Shares:2.38M

Float Shares:2.33M

Volume Ratio:0.94

T/O Rate:71.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-37.5600

EPS(LYR):-54.8768

ROE:-1625.11%

ROA:-190.09%

PB:-7.81

PE(LYR):-0.08

Loading ...

Overview Company News Filings

Artelo announces expansion opportunity for ART27.13 in muscle preservation

Artelo Biosciences initiates non-clinical study of ART27.13 for GLP-1-related muscle loss; incretin market climbs to $200 billion by 2030 forecast

Artelo Biosciences Expands Art27.13 Development as a Potential Companion Therapy to Glp-1 Treatments

THOMSON REUTERS

Artelo Biosciences expands ART27.13 into glaucoma via fully funded investigator-sponsored clinical study; glaucoma market totals $16.3 billion

Artelo Biosciences files to sell 4.27M shares of common stock for holders

Artelo Biosciences Inc - May Receive up to $50 Mln in Gross Proceeds From Sales to Square Gate - SEC Filing

THOMSON REUTERS

Artelo reports 6.38% mean weight gain in interim CAReS trial results for ART27.13

Artelo Biosciences files to sell 1.64M shares of common stock

Artelo Biosciences Secures Bridge Financing Through Note Issuance

Artelo Biosciences issues USD 350,300 in 12% unregistered bridge notes in private placement

BUZZ-U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies

Top Midday Gainers

MT Newswires Live

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:39 AM

BUZZ-U.S. STOCKS ON THE MOVE-Tencent, Air Products, Protagonist

Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study

BRIEF-Artelo Announces Third-Party Fully Funded Clinical Study Agreement To Evaluate Art27.13 In Glaucoma Patients

Artelo Biosciences Shares Jump 30% Premarket After Co Plans UK Study of Glaucoma Drug

THOMSON REUTERS

BUZZ-Artelo Biosciences jumps as it plans UK study of glaucoma drug

Artelo announces third-party fully funded clinical study agreement for ART27.13

Artelo Biosciences signs investigator-initiated clinical study to test ART27.13 in glaucoma patients

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ARTL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARTL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTL\",,,,,undefined,":{"symbol":"ARTL","market":"US","secType":"STK","nameCN":"Artelo Biosciences, Inc.","latestPrice":4.18,"timestamp":1774543736753,"preClose":4.85,"halted":0,"volume":1658491,"delay":0,"changeRate":-0.13814432989690723,"floatShares":2331500,"shares":2377700,"eps":-37.56,"marketStatus":"Trading","change":-0.67,"latestTime":"03-26 12:49:00 EDT","open":2.955,"high":4.51,"low":2.955,"amount":5798368.4696592,"amplitude":0.320619,"askPrice":4.18,"askSize":46,"bidPrice":4.07,"bidSize":50,"shortable":0,"etf":0,"ttmEps":-37.56,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1774555200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":4.85,"preHourTrading":{"tag":"盘前","latestPrice":2.92,"preClose":4.85,"latestTime":"09:29 EDT","volume":375505,"amount":1184077.588369,"timestamp":1774531783577,"change":-1.93,"changeRate":-0.397938,"amplitude":0.346392},"postHourTrading":{"tag":"盘后","latestPrice":4.02,"preClose":4.85,"latestTime":"19:59 EDT","volume":157882,"amount":716369.7598,"timestamp":1774483188062,"change":-0.83,"changeRate":-0.171134,"amplitude":0.231237},"volumeRatio":0.935233},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTL\",,,,,undefined,":{"symbol":"ARTL","floatShares":2331500,"roa":"-190.09%","roe":"-1625.11%","lyrEps":-54.876786,"volumeRatio":0.935233,"shares":2377700,"dividePrice":0,"high":4.51,"amplitude":0.320619,"preClose":4.85,"low":2.955,"week52Low":2.955,"pbRate":"-7.81","week52High":85.8,"institutionHeld":0,"latestPrice":4.18,"committee":0.041667,"eps":-37.56,"divideRate":0,"volume":1658491,"delay":0,"ttmEps":-37.56,"open":2.955,"prevYearClose":3.66,"prevWeekClose":7.97,"prevMonthClose":3.57,"prevQuarterClose":3.66,"fiveDayClose":7.16,"twentyDayClose":3.72,"sixtyDayClose":3.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-10","symbol":"ARTL","defaultRemindTime":1773149400000,"type":"split","dateTimestamp":1773115200000,"forFactor":3,"toFactor":1,"ratio":3},{"date":"2026-02-24","symbol":"ARTL","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771923600000,"name":null,"time":"Pre-Market","dateTimestamp":1771909200000,"actualEps":null},{"market":"US","date":"2025-11-12","symbol":"ARTL","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-3.97},{"market":"US","date":"2025-08-13","symbol":"ARTL","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-5.61},{"market":"US","date":"2025-06-13","symbol":"ARTL","defaultRemindTime":1749821400000,"type":"split","dateTimestamp":1749787200000,"forFactor":6,"toFactor":1,"ratio":6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1763611200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARTL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARTL","date":"2026-03-25","current":-0.129127,"percent":0.914334,"low":-6.309706,"twenty":-1.947726,"median":-0.580825,"eighty":-0.385177,"high":-0.181478,"avg":-1.246199,"sd":1.394265,"marketCap":4100813},"quantilePoints":[{"date":"2021-03-26","current":-5.485015,"twenty":-10.12268,"median":-5.883887,"eighty":-1.688082,"marketCap":26238333},{"date":"2021-04-01","current":-5.51786,"twenty":-10.12268,"median":-5.883887,"eighty":-1.688341,"marketCap":26395449},{"date":"2021-04-09","current":-4.992349,"twenty":-10.12268,"median":-5.883887,"eighty":-1.695937,"marketCap":23881596},{"date":"2021-04-16","current":-5.082819,"twenty":-10.116154,"median":-5.883887,"eighty":-1.70037,"marketCap":26834405},{"date":"2021-04-23","current":-5.652445,"twenty":-10.114522,"median":-5.82563,"eighty":-1.702873,"marketCap":29841709},{"date":"2021-04-30","current":-5.783897,"twenty":-10.114522,"median":-5.849623,"eighty":-1.710858,"marketCap":30535702},{"date":"2021-05-07","current":-5.480961,"twenty":-10.114522,"median":-5.82563,"eighty":-1.715607,"marketCap":28936372},{"date":"2021-05-14","current":-4.867093,"twenty":-10.114522,"median":-5.808244,"eighty":-1.721566,"marketCap":25695498},{"date":"2021-05-21","current":-5.217875,"twenty":-10.114522,"median":-5.774399,"eighty":-1.733535,"marketCap":27547427},{"date":"2021-05-28","current":-5.437113,"twenty":-9.85301,"median":-5.718645,"eighty":-1.740405,"marketCap":28704880},{"date":"2021-06-04","current":-5.217875,"twenty":-9.767026,"median":-5.705594,"eighty":-1.745341,"marketCap":27547427},{"date":"2021-06-11","current":-5.393265,"twenty":-9.623245,"median":-5.676472,"eighty":-1.752925,"marketCap":28473389},{"date":"2021-06-18","current":-5.174027,"twenty":-9.536549,"median":-5.658715,"eighty":-1.758299,"marketCap":27315935},{"date":"2021-06-25","current":-5.524809,"twenty":-9.536549,"median":-5.652445,"eighty":-1.773005,"marketCap":29167863},{"date":"2021-07-02","current":-5.086332,"twenty":-9.457797,"median":-5.627873,"eighty":-1.794755,"marketCap":26852953},{"date":"2021-07-09","current":-4.910941,"twenty":-9.4,"median":-5.578957,"eighty":-1.809087,"marketCap":25926989},{"date":"2021-07-16","current":-3.723599,"twenty":-9.392055,"median":-5.568656,"eighty":-1.81937,"marketCap":24493966},{"date":"2021-07-23","current":-3.760835,"twenty":-9.392055,"median":-5.524809,"eighty":-1.826634,"marketCap":24738906},{"date":"2021-07-30","current":-3.72211,"twenty":-9.392055,"median":-5.51786,"eighty":-1.83467,"marketCap":24484169},{"date":"2021-08-06","current":-3.538164,"twenty":-9.392055,"median":-5.481719,"eighty":-1.83898,"marketCap":23274166},{"date":"2021-08-13","current":-3.232084,"twenty":-9.392055,"median":-5.480961,"eighty":-1.847552,"marketCap":21260763},{"date":"2021-08-20","current":-3.30246,"twenty":-9.392055,"median":-5.415189,"eighty":-1.861355,"marketCap":21723699},{"date":"2021-08-27","current":-3.6495,"twenty":-9.392055,"median":-5.393265,"eighty":-1.880263,"marketCap":24006536},{"date":"2021-09-03","current":-3.407093,"twenty":-9.392055,"median":-5.387264,"eighty":-1.898191,"marketCap":22411980},{"date":"2021-09-10","current":-3.313631,"twenty":-9.392055,"median":-5.353637,"eighty":-1.912325,"marketCap":21797181},{"date":"2021-09-17","current":-3.165059,"twenty":-9.392055,"median":-5.347524,"eighty":-1.928712,"marketCap":20819871},{"date":"2021-09-24","current":-3.023563,"twenty":-9.392055,"median":-5.30557,"eighty":-1.942592,"marketCap":19889100},{"date":"2021-10-01","current":-2.904407,"twenty":-9.392055,"median":-5.287949,"eighty":-1.950058,"marketCap":19105294},{"date":"2021-10-08","current":-2.753602,"twenty":-9.392055,"median":-5.26245,"eighty":-1.959188,"marketCap":18113288},{"date":"2021-10-15","current":-2.848553,"twenty":-9.392055,"median":-5.255105,"eighty":-1.960607,"marketCap":18737884},{"date":"2021-10-22","current":-2.755091,"twenty":-9.392055,"median":-5.217875,"eighty":-1.965901,"marketCap":18123086},{"date":"2021-10-29","current":-2.664608,"twenty":-9.392055,"median":-5.217875,"eighty":-1.9688,"marketCap":17527882},{"date":"2021-11-05","current":-4.282139,"twenty":-9.392055,"median":-5.181722,"eighty":-1.979618,"marketCap":28168062},{"date":"2021-11-12","current":-3.299854,"twenty":-9.392055,"median":-5.174027,"eighty":-1.993347,"marketCap":21706553},{"date":"2021-11-19","current":-2.875736,"twenty":-9.392055,"median":-5.130179,"eighty":-1.994663,"marketCap":18916690},{"date":"2021-11-26","current":-2.647107,"twenty":-9.392055,"median":-5.130179,"eighty":-1.996481,"marketCap":17412760},{"date":"2021-12-03","current":-3.221064,"twenty":-9.392055,"median":-5.126636,"eighty":-1.999727,"marketCap":23955053},{"date":"2021-12-10","current":-3.564614,"twenty":-9.392055,"median":-5.107304,"eighty":-2.006015,"marketCap":26510035},{"date":"2021-12-17","current":-3.327428,"twenty":-9.392055,"median":-5.086332,"eighty":-2.012713,"marketCap":24746082},{"date":"2021-12-23","current":-3.442893,"twenty":-9.392055,"median":-5.042484,"eighty":-2.012713,"marketCap":25604793},{"date":"2021-12-31","current":-2.952026,"twenty":-9.392055,"median":-5.025082,"eighty":-2.024007,"marketCap":21954218},{"date":"2022-01-07","current":-2.843387,"twenty":-9.392055,"median":-4.995184,"eighty":-2.034193,"marketCap":21146268},{"date":"2022-01-14","current":-2.176893,"twenty":-9.392055,"median":-4.992349,"eighty":-2.043348,"marketCap":18612437},{"date":"2022-01-21","current":-1.951288,"twenty":-9.392055,"median":-4.966651,"eighty":-2.041519,"marketCap":16683513},{"date":"2022-01-28","current":-1.930509,"twenty":-9.392055,"median":-4.951203,"eighty":-2.012713,"marketCap":16505849},{"date":"2022-02-04","current":-2.028469,"twenty":-9.392055,"median":-4.889017,"eighty":-2.012713,"marketCap":17343406},{"date":"2022-02-11","current":-1.936446,"twenty":-9.392055,"median":-4.82611,"eighty":-2.012713,"marketCap":16556610},{"date":"2022-02-18","current":-1.946835,"twenty":-9.392055,"median":-4.75592,"eighty":-2.003533,"marketCap":16645442},{"date":"2022-02-25","current":-1.927045,"twenty":-9.392055,"median":-4.727051,"eighty":-1.995488,"marketCap":16476238},{"date":"2022-03-04","current":-1.931498,"twenty":-9.392055,"median":-4.684711,"eighty":-1.993562,"marketCap":16514309},{"date":"2022-03-11","current":-2.029458,"twenty":-9.392055,"median":-4.639839,"eighty":-1.993562,"marketCap":17351867},{"date":"2022-03-18","current":-1.856791,"twenty":-9.392055,"median":-4.604007,"eighty":-1.97066,"marketCap":15875564},{"date":"2022-03-25","current":-1.661288,"twenty":-9.392055,"median":-4.505987,"eighty":-1.961864,"marketCap":20109893},{"date":"2022-04-01","current":-1.59035,"twenty":-9.392055,"median":-4.364825,"eighty":-1.951288,"marketCap":19251182},{"date":"2022-04-08","current":-1.514519,"twenty":-9.392055,"median":-4.327317,"eighty":-1.938385,"marketCap":18333250},{"date":"2022-04-14","current":-1.502638,"twenty":-9.348707,"median":-4.275904,"eighty":-1.927738,"marketCap":18189427},{"date":"2022-04-22","current":-1.28493,"twenty":-9.175316,"median":-4.258828,"eighty":-1.917843,"marketCap":15554076},{"date":"2022-04-29","current":-1.333504,"twenty":-9.175316,"median":-4.204084,"eighty":-1.880252,"marketCap":16142060},{"date":"2022-05-06","current":-1.256624,"twenty":-9.175316,"median":-4.179961,"eighty":-1.857385,"marketCap":15211438},{"date":"2022-05-13","current":-1.129736,"twenty":-9.175316,"median":-4.148761,"eighty":-1.834256,"marketCap":13980478},{"date":"2022-05-20","current":-1.130761,"twenty":-9.175316,"median":-4.127751,"eighty":-1.806206,"marketCap":13993168},{"date":"2022-05-27","current":-1.177591,"twenty":-9.175316,"median":-4.107265,"eighty":-1.756936,"marketCap":14572692},{"date":"2022-06-03","current":-1.227156,"twenty":-9.175316,"median":-4.098527,"eighty":-1.741456,"marketCap":15186057},{"date":"2022-06-10","current":-1.246982,"twenty":-9.175316,"median":-4.033443,"eighty":-1.712738,"marketCap":15431403},{"date":"2022-06-17","current":-1.068891,"twenty":-9.175316,"median":-4.017474,"eighty":-1.688406,"marketCap":13227520},{"date":"2022-06-24","current":-1.114353,"twenty":-9.175316,"median":-4.00149,"eighty":-1.683087,"marketCap":13790124},{"date":"2022-07-01","current":-1.059661,"twenty":-9.175316,"median":-3.984251,"eighty":-1.648288,"marketCap":13113307},{"date":"2022-07-08","current":-1.128368,"twenty":-9.175316,"median":-3.975064,"eighty":-1.598876,"marketCap":13963558},{"date":"2022-07-15","current":-1.162209,"twenty":-9.045272,"median":-3.952924,"eighty":-1.572528,"marketCap":14382338},{"date":"2022-07-22","current":-1.226131,"twenty":-8.958576,"median":-3.909779,"eighty":-1.533614,"marketCap":15173367},{"date":"2022-07-29","current":-1.162551,"twenty":-8.958576,"median":-3.886931,"eighty":-1.511164,"marketCap":14386568},{"date":"2022-08-05","current":-1.288685,"twenty":-8.958576,"median":-3.872543,"eighty":-1.458499,"marketCap":15947476},{"date":"2022-08-12","current":-0.856036,"twenty":-8.958576,"median":-3.864492,"eighty":-1.409293,"marketCap":10762087},{"date":"2022-08-19","current":-1.097714,"twenty":-8.958576,"median":-3.860888,"eighty":-1.399759,"marketCap":13800460},{"date":"2022-08-26","current":-0.869588,"twenty":-8.958576,"median":-3.835307,"eighty":-1.360732,"marketCap":10932463},{"date":"2022-09-02","current":-0.878623,"twenty":-8.958576,"median":-3.835307,"eighty":-1.347042,"marketCap":11046047},{"date":"2022-09-09","current":-0.880882,"twenty":-8.900779,"median":-3.832945,"eighty":-1.333644,"marketCap":11074443},{"date":"2022-09-16","current":-0.898951,"twenty":-8.814083,"median":-3.809627,"eighty":-1.308553,"marketCap":11301611},{"date":"2022-09-23","current":-0.720516,"twenty":-8.814083,"median":-3.798071,"eighty":-1.29894,"marketCap":9058327},{"date":"2022-09-30","current":-0.779241,"twenty":-8.814083,"median":-3.769386,"eighty":-1.285599,"marketCap":9796623},{"date":"2022-10-07","current":-0.774724,"twenty":-8.814083,"median":-3.744262,"eighty":-1.265832,"marketCap":9739831},{"date":"2022-10-14","current":-0.715999,"twenty":-8.814083,"median":-3.725419,"eighty":-1.256447,"marketCap":9001535},{"date":"2022-10-21","current":-0.643721,"twenty":-8.813524,"median":-3.725304,"eighty":-1.25458,"marketCap":8092862},{"date":"2022-10-28","current":-0.686636,"twenty":-8.810109,"median":-3.722879,"eighty":-1.240599,"marketCap":8632387},{"date":"2022-11-04","current":-0.614358,"twenty":-8.778392,"median":-3.696574,"eighty":-1.231855,"marketCap":7723714},{"date":"2022-11-11","current":-0.624971,"twenty":-8.714691,"median":-3.664062,"eighty":-1.224056,"marketCap":7910255},{"date":"2022-11-18","current":-0.566309,"twenty":-8.681812,"median":-3.640638,"eighty":-1.214265,"marketCap":7167776},{"date":"2022-11-25","current":-0.584336,"twenty":-8.611269,"median":-3.589948,"eighty":-1.208984,"marketCap":7395946},{"date":"2022-12-02","current":-0.57759,"twenty":-8.310578,"median":-3.573538,"eighty":-1.205875,"marketCap":7310561},{"date":"2022-12-09","current":-0.609177,"twenty":-8.310578,"median":-3.547276,"eighty":-1.193862,"marketCap":7710357},{"date":"2022-12-16","current":-0.688145,"twenty":-8.103024,"median":-3.537419,"eighty":-1.185121,"marketCap":8709848},{"date":"2022-12-23","current":-0.654302,"twenty":-7.958328,"median":-3.500556,"eighty":-1.176969,"marketCap":8281495},{"date":"2022-12-30","current":-0.652045,"twenty":-7.958328,"median":-3.488239,"eighty":-1.171893,"marketCap":8252938},{"date":"2023-01-06","current":-0.708451,"twenty":-7.958328,"median":-3.481507,"eighty":-1.162551,"marketCap":8966860},{"date":"2023-01-13","current":-0.735525,"twenty":-7.958328,"median":-3.463938,"eighty":-1.156568,"marketCap":9309542},{"date":"2023-01-20","current":-0.676864,"twenty":-7.764464,"median":-3.442893,"eighty":-1.155435,"marketCap":8567064},{"date":"2023-01-27","current":-0.721988,"twenty":-7.764464,"median":-3.408626,"eighty":-1.143956,"marketCap":9138201},{"date":"2023-02-03","current":-0.692657,"twenty":-7.596585,"median":-3.397389,"eighty":-1.13607,"marketCap":8766962},{"date":"2023-02-10","current":-0.681376,"twenty":-7.291174,"median":-3.386744,"eighty":-1.133276,"marketCap":8624177},{"date":"2023-02-17","current":-0.67912,"twenty":-7.209692,"median":-3.369707,"eighty":-1.129189,"marketCap":8595620},{"date":"2023-02-24","current":-0.66107,"twenty":-7.172284,"median":-3.328566,"eighty":-1.125755,"marketCap":8367165},{"date":"2023-03-03","current":-0.622715,"twenty":-7.172284,"median":-3.313631,"eighty":-1.118396,"marketCap":7881698},{"date":"2023-03-10","current":-0.527954,"twenty":-7.112515,"median":-3.302075,"eighty":-1.115725,"marketCap":6682309},{"date":"2023-03-17","current":-0.482829,"twenty":-7.050416,"median":-3.276767,"eighty":-1.107906,"marketCap":6111172},{"date":"2023-03-24","current":-0.471548,"twenty":-6.974111,"median":-3.246311,"eighty":-1.10511,"marketCap":5968387},{"date":"2023-03-31","current":-0.523441,"twenty":-6.871168,"median":-3.233399,"eighty":-1.099043,"marketCap":6625196},{"date":"2023-04-06","current":-0.54826,"twenty":-6.871168,"median":-3.219908,"eighty":-1.096423,"marketCap":6939321},{"date":"2023-04-14","current":-0.747016,"twenty":-6.831636,"median":-3.204569,"eighty":-1.088336,"marketCap":7532162},{"date":"2023-04-21","current":-0.810004,"twenty":-6.74053,"median":-3.173251,"eighty":-1.081316,"marketCap":8167267},{"date":"2023-04-28","current":-0.552275,"twenty":-6.696269,"median":-3.142002,"eighty":-1.072453,"marketCap":5568591},{"date":"2023-05-05","current":-0.464478,"twenty":-6.691921,"median":-3.126334,"eighty":-1.06636,"marketCap":4683328},{"date":"2023-05-12","current":-0.478639,"twenty":-6.691921,"median":-3.078622,"eighty":-1.060755,"marketCap":4826112},{"date":"2023-05-19","current":-0.48585,"twenty":-6.691921,"median":-3.056683,"eighty":-1.054709,"marketCap":4997454},{"date":"2023-05-24","current":-0.502508,"twenty":-6.574594,"median":-3.048069,"eighty":-1.047566,"marketCap":5168795},{"date":"2023-06-06","current":-0.521942,"twenty":-6.572422,"median":-2.987071,"eighty":-1.042018,"marketCap":5368693},{"date":"2023-06-16","current":-0.560782,"twenty":-6.371826,"median":-2.947766,"eighty":-1.032939,"marketCap":5768204},{"date":"2023-06-23","current":-0.535823,"twenty":-6.268508,"median":-2.904221,"eighty":-1.019753,"marketCap":5511477},{"date":"2023-07-12","current":-0.566362,"twenty":-6.105371,"median":-2.841155,"eighty":-1.002259,"marketCap":5825603},{"date":"2023-07-20","current":-0.533047,"twenty":-6.058655,"median":-2.791955,"eighty":-0.997258,"marketCap":5482920},{"date":"2023-07-28","current":-0.546928,"twenty":-5.956229,"median":-2.764772,"eighty":-0.987074,"marketCap":5625705},{"date":"2023-08-04","current":-0.555257,"twenty":-5.930492,"median":-2.755277,"eighty":-0.966953,"marketCap":5711376},{"date":"2023-08-11","current":-0.596196,"twenty":-5.883887,"median":-2.745223,"eighty":-0.945535,"marketCap":5625705},{"date":"2023-08-18","current":-0.605517,"twenty":-5.862768,"median":-2.692284,"eighty":-0.931472,"marketCap":5713662},{"date":"2023-08-25","current":-0.576465,"twenty":-5.799203,"median":-2.661629,"eighty":-0.914708,"marketCap":5439521},{"date":"2023-09-01","current":-0.581052,"twenty":-5.717901,"median":-2.598354,"eighty":-0.902712,"marketCap":5482807},{"date":"2023-09-08","current":-0.556281,"twenty":-5.675771,"median":-2.518722,"eighty":-0.895011,"marketCap":5249066},{"date":"2023-09-15","current":-0.443434,"twenty":-5.651803,"median":-2.369743,"eighty":-0.884539,"marketCap":4184247},{"date":"2023-09-22","current":-0.455667,"twenty":-5.571194,"median":-2.205957,"eighty":-0.878623,"marketCap":4299675},{"date":"2023-09-28","current":-0.461783,"twenty":-5.524809,"median":-2.151661,"eighty":-0.869588,"marketCap":4357388},{"date":"2023-10-05","current":-0.428144,"twenty":-5.484,"median":-2.132988,"eighty":-0.86443,"marketCap":4039963},{"date":"2023-10-12","current":-0.461783,"twenty":-5.477932,"median":-2.118124,"eighty":-0.855706,"marketCap":4357388},{"date":"2023-10-20","current":-0.443434,"twenty":-5.393265,"median":-2.104165,"eighty":-0.840226,"marketCap":4184247},{"date":"2023-11-02","current":-0.376094,"twenty":-5.30557,"median":-2.091581,"eighty":-0.810004,"marketCap":3548819},{"date":"2023-11-10","current":-0.403678,"twenty":-5.262014,"median":-2.048753,"eighty":-0.803825,"marketCap":3809108},{"date":"2023-11-17","current":-0.369265,"twenty":-5.217875,"median":-2.028469,"eighty":-0.787307,"marketCap":3528330},{"date":"2023-11-24","current":-0.427197,"twenty":-5.195108,"median":-2.012713,"eighty":-0.781048,"marketCap":4081867},{"date":"2023-12-01","current":-0.460572,"twenty":-5.130327,"median":-2.003236,"eighty":-0.774629,"marketCap":4400763},{"date":"2023-12-08","current":-0.467247,"twenty":-5.130179,"median":-1.99367,"eighty":-0.7626,"marketCap":4464542},{"date":"2023-12-15","current":-0.457234,"twenty":-5.088152,"median":-1.96629,"eighty":-0.757185,"marketCap":4368873},{"date":"2023-12-21","current":-0.433872,"twenty":-5.042484,"median":-1.959248,"eighty":-0.742628,"marketCap":4145646},{"date":"2023-12-29","current":-0.468081,"twenty":-4.994617,"median":-1.949537,"eighty":-0.738034,"marketCap":4472514},{"date":"2024-01-05","current":-0.480597,"twenty":-4.978514,"median":-1.936446,"eighty":-0.735525,"marketCap":4592100},{"date":"2024-01-12","current":-0.487272,"twenty":-4.910941,"median":-1.922098,"eighty":-0.725038,"marketCap":4655880},{"date":"2024-01-19","current":-0.473922,"twenty":-4.774737,"median":-1.898126,"eighty":-0.720516,"marketCap":4528321},{"date":"2024-01-26","current":-0.457234,"twenty":-4.691702,"median":-1.85976,"eighty":-0.713763,"marketCap":4368873},{"date":"2024-02-02","current":-0.453897,"twenty":-4.639839,"median":-1.833841,"eighty":-0.703938,"marketCap":4336984},{"date":"2024-02-09","current":-0.470584,"twenty":-4.471769,"median":-1.7819,"eighty":-0.691153,"marketCap":4496432},{"date":"2024-02-16","current":-0.577383,"twenty":-4.282139,"median":-1.747253,"eighty":-0.688145,"marketCap":5516899},{"date":"2024-02-23","current":-0.560696,"twenty":-4.230273,"median":-1.716324,"eighty":-0.683632,"marketCap":5357451},{"date":"2024-03-01","current":-0.513971,"twenty":-4.177108,"median":-1.693113,"eighty":-0.677337,"marketCap":4910996},{"date":"2024-03-08","current":-0.475323,"twenty":-4.125574,"median":-1.663551,"eighty":-0.675058,"marketCap":4541715},{"date":"2024-03-15","current":-0.500621,"twenty":-4.091308,"median":-1.613715,"eighty":-0.668867,"marketCap":4783438},{"date":"2024-03-22","current":-0.500621,"twenty":-4.012059,"median":-1.572528,"eighty":-0.662544,"marketCap":4783438},{"date":"2024-03-28","current":-0.510789,"twenty":-3.983286,"median":-1.532186,"eighty":-0.653065,"marketCap":4744719},{"date":"2024-04-05","current":-0.531985,"twenty":-3.943359,"median":-1.502638,"eighty":-0.647533,"marketCap":4941608},{"date":"2024-04-12","current":-0.548664,"twenty":-3.875639,"median":-1.436515,"eighty":-0.643721,"marketCap":5096538},{"date":"2024-04-19","current":-0.444769,"twenty":-3.861179,"median":-1.401297,"eighty":-0.633996,"marketCap":4131456},{"date":"2024-04-26","current":-0.465617,"twenty":-3.835307,"median":-1.360724,"eighty":-0.628225,"marketCap":4325118},{"date":"2024-05-03","current":-0.479516,"twenty":-3.815227,"median":-1.344292,"eighty":-0.622715,"marketCap":4454226},{"date":"2024-05-10","current":-0.482991,"twenty":-3.780733,"median":-1.318026,"eighty":-0.614425,"marketCap":4486503},{"date":"2024-05-17","current":-0.457067,"twenty":-3.740493,"median":-1.29894,"eighty":-0.604835,"marketCap":4389672},{"date":"2024-05-24","current":-0.507479,"twenty":-3.723525,"median":-1.282395,"eighty":-0.596225,"marketCap":4873827},{"date":"2024-05-31","current":-0.443624,"twenty":-3.695456,"median":-1.261338,"eighty":-0.587093,"marketCap":4260564},{"date":"2024-06-07","current":-0.480593,"twenty":-3.656046,"median":-1.256397,"eighty":-0.579997,"marketCap":4615611},{"date":"2024-06-14","current":-0.446985,"twenty":-3.59949,"median":-1.248008,"eighty":-0.576465,"marketCap":4292841},{"date":"2024-06-21","current":-0.423459,"twenty":-3.576144,"median":-1.231992,"eighty":-0.570421,"marketCap":4066902},{"date":"2024-06-28","current":-0.437743,"twenty":-3.556024,"median":-1.226131,"eighty":-0.566853,"marketCap":4204079},{"date":"2024-07-05","current":-0.457067,"twenty":-3.538864,"median":-1.223128,"eighty":-0.565871,"marketCap":4389672},{"date":"2024-07-12","current":-0.42682,"twenty":-3.520105,"median":-1.209723,"eighty":-0.560713,"marketCap":4099179},{"date":"2024-07-15","current":-0.435188,"twenty":-3.510735,"median":-1.209381,"eighty":-0.559772,"marketCap":4179548},{"date":"2024-08-02","current":-0.453706,"twenty":-3.471416,"median":-1.200055,"eighty":-0.557329,"marketCap":4357395},{"date":"2024-08-09","current":-0.440263,"twenty":-3.458479,"median":-1.18776,"eighty":-0.555165,"marketCap":4228287},{"date":"2024-08-16","current":-0.414332,"twenty":-3.417735,"median":-1.178812,"eighty":-0.551802,"marketCap":4324795},{"date":"2024-08-23","current":-0.386532,"twenty":-3.40687,"median":-1.176035,"eighty":-0.54813,"marketCap":4034625},{"date":"2024-08-30","current":-0.405086,"twenty":-3.404895,"median":-1.16625,"eighty":-0.545817,"marketCap":4228287},{"date":"2024-09-06","current":-0.392717,"twenty":-3.395342,"median":-1.161086,"eighty":-0.539671,"marketCap":4099179},{"date":"2024-09-13","current":-0.358733,"twenty":-3.386682,"median":-1.155932,"eighty":-0.534713,"marketCap":3744454},{"date":"2024-09-20","current":-0.348281,"twenty":-3.342294,"median":-1.144947,"eighty":-0.52908,"marketCap":3635358},{"date":"2024-09-27","current":-0.333964,"twenty":-3.317285,"median":-1.136718,"eighty":-0.52165,"marketCap":3485916},{"date":"2024-10-04","current":-0.346086,"twenty":-3.312195,"median":-1.13493,"eighty":-0.517309,"marketCap":3612441},{"date":"2024-10-11","current":-0.337056,"twenty":-3.306428,"median":-1.129736,"eighty":-0.513391,"marketCap":3518193},{"date":"2024-10-18","current":-0.367979,"twenty":-3.281522,"median":-1.125749,"eighty":-0.508451,"marketCap":3840963},{"date":"2024-10-25","current":-0.358702,"twenty":-3.252531,"median":-1.118125,"eighty":-0.503911,"marketCap":3744132},{"date":"2024-10-31","current":-0.364887,"twenty":-3.239531,"median":-1.116247,"eighty":-0.501742,"marketCap":3808686},{"date":"2024-11-08","current":-0.374163,"twenty":-3.220139,"median":-1.107906,"eighty":-0.498487,"marketCap":3905517},{"date":"2024-11-15","current":-0.382186,"twenty":-3.192927,"median":-1.105674,"eighty":-0.494861,"marketCap":3485916},{"date":"2024-11-22","current":-0.39988,"twenty":-3.145937,"median":-1.099043,"eighty":-0.491004,"marketCap":3647301},{"date":"2024-11-29","current":-0.371569,"twenty":-3.127226,"median":-1.096623,"eighty":-0.488607,"marketCap":3389085},{"date":"2024-12-06","current":-0.410496,"twenty":-3.070066,"median":-1.09018,"eighty":-0.485618,"marketCap":3744132},{"date":"2024-12-13","current":-0.389263,"twenty":-3.027807,"median":-1.081316,"eighty":-0.483483,"marketCap":3550470},{"date":"2024-12-20","current":-0.334766,"twenty":-2.975797,"median":-1.072453,"eighty":-0.48149,"marketCap":3053404},{"date":"2024-12-27","current":-0.369977,"twenty":-2.948618,"median":-1.068891,"eighty":-0.480595,"marketCap":3374560},{"date":"2025-01-03","current":-0.385724,"twenty":-2.904258,"median":-1.063079,"eighty":-0.478639,"marketCap":3518193},{"date":"2025-01-10","current":-0.414035,"twenty":-2.862852,"median":-1.054682,"eighty":-0.477237,"marketCap":3776409},{"date":"2025-01-17","current":-0.403418,"twenty":-2.83423,"median":-1.045614,"eighty":-0.47542,"marketCap":3679578},{"date":"2025-01-24","current":-0.411982,"twenty":-2.792253,"median":-1.033341,"eighty":-0.473922,"marketCap":3757688},{"date":"2025-01-31","current":-0.414035,"twenty":-2.792253,"median":-1.017242,"eighty":-0.470958,"marketCap":3776409},{"date":"2025-02-07","current":-0.488348,"twenty":-2.791929,"median":-0.997431,"eighty":-0.470026,"marketCap":4454226},{"date":"2025-02-14","current":-0.491887,"twenty":-2.791929,"median":-0.982522,"eighty":-0.470026,"marketCap":4486503},{"date":"2025-02-21","current":-0.424651,"twenty":-2.791929,"median":-0.958483,"eighty":-0.467936,"marketCap":3873240},{"date":"2025-02-28","current":-0.373339,"twenty":-2.791929,"median":-0.942336,"eighty":-0.467247,"marketCap":3405223},{"date":"2025-03-07","current":-0.328486,"twenty":-2.791955,"median":-0.9151,"eighty":-0.466243,"marketCap":3227700},{"date":"2025-03-14","current":-0.317551,"twenty":-2.791955,"median":-0.904642,"eighty":-0.464478,"marketCap":3120261},{"date":"2025-03-21","current":-0.33024,"twenty":-2.791955,"median":-0.903491,"eighty":-0.461783,"marketCap":3244940},{"date":"2025-03-28","current":-0.322226,"twenty":-2.791955,"median":-0.896692,"eighty":-0.461645,"marketCap":3166195},{"date":"2025-04-04","current":-0.286431,"twenty":-2.791955,"median":-0.884539,"eighty":-0.460572,"marketCap":2814469},{"date":"2025-04-11","current":-0.27451,"twenty":-2.791929,"median":-0.879753,"eighty":-0.458684,"marketCap":2697339},{"date":"2025-04-17","current":-0.323896,"twenty":-2.791929,"median":-0.869588,"eighty":-0.457234,"marketCap":3182601},{"date":"2025-04-25","current":-0.343931,"twenty":-2.791955,"median":-0.856036,"eighty":-0.45693,"marketCap":3379462},{"date":"2025-05-02","current":-0.337252,"twenty":-2.791955,"median":-0.828932,"eighty":-0.453706,"marketCap":3313842},{"date":"2025-05-09","current":-0.333913,"twenty":-2.791955,"median":-0.804126,"eighty":-0.450559,"marketCap":3281032},{"date":"2025-05-16","current":-0.317465,"twenty":-2.791955,"median":-0.792793,"eighty":-0.450317,"marketCap":3084170},{"date":"2025-05-23","current":-0.322531,"twenty":-2.791955,"median":-0.779241,"eighty":-0.447222,"marketCap":3133385},{"date":"2025-05-30","current":-0.342794,"twenty":-2.791955,"median":-0.774724,"eighty":-0.446985,"marketCap":3330247},{"date":"2025-06-06","current":-0.371501,"twenty":-2.791955,"median":-0.761857,"eighty":-0.443657,"marketCap":3609135},{"date":"2025-06-13","current":-0.398789,"twenty":-2.791955,"median":-0.744864,"eighty":-0.440547,"marketCap":3874236},{"date":"2025-06-20","current":-0.341668,"twenty":-2.792029,"median":-0.738241,"eighty":-0.437658,"marketCap":3319306},{"date":"2025-06-27","current":-0.386251,"twenty":-2.792029,"median":-0.734068,"eighty":-0.43387,"marketCap":3752431},{"date":"2025-07-03","current":-0.565518,"twenty":-2.792029,"median":-0.725769,"eighty":-0.433434,"marketCap":5494003},{"date":"2025-07-11","current":-2.005928,"twenty":-2.792029,"median":-0.724641,"eighty":-0.433434,"marketCap":19487587},{"date":"2025-07-18","current":-1.102908,"twenty":-2.792029,"median":-0.724641,"eighty":-0.433434,"marketCap":10714754},{"date":"2025-07-25","current":-0.968476,"twenty":-2.792029,"median":-0.724641,"eighty":-0.433434,"marketCap":9408744},{"date":"2025-08-01","current":-0.834747,"twenty":-2.792029,"median":-0.724641,"eighty":-0.433434,"marketCap":8109571},{"date":"2025-08-08","current":-0.635562,"twenty":-2.792029,"median":-0.719593,"eighty":-0.433434,"marketCap":6174488},{"date":"2025-08-15","current":-1.269586,"twenty":-2.792029,"median":-0.714869,"eighty":-0.433434,"marketCap":13334459},{"date":"2025-08-22","current":-1.199123,"twenty":-2.792029,"median":-0.714869,"eighty":-0.433434,"marketCap":12594390},{"date":"2025-08-29","current":-1.137468,"twenty":-2.792029,"median":-0.714869,"eighty":-0.433434,"marketCap":11946830},{"date":"2025-09-05","current":-0.547344,"twenty":-2.792104,"median":-0.710707,"eighty":-0.433007,"marketCap":5748751},{"date":"2025-09-12","current":-0.919297,"twenty":-2.792029,"median":-0.712235,"eighty":-0.433434,"marketCap":9655381},{"date":"2025-09-19","current":-1.069539,"twenty":-2.792029,"median":-0.712235,"eighty":-0.433434,"marketCap":11233368},{"date":"2025-09-26","current":-1.069539,"twenty":-2.792029,"median":-0.713353,"eighty":-0.433434,"marketCap":11233368},{"date":"2025-10-03","current":-0.92719,"twenty":-2.792029,"median":-0.713353,"eighty":-0.433434,"marketCap":9738279},{"date":"2025-10-10","current":-0.932961,"twenty":-2.792029,"median":-0.713353,"eighty":-0.433434,"marketCap":9798891},{"date":"2025-10-17","current":-0.939828,"twenty":-2.792029,"median":-0.713353,"eighty":-0.433434,"marketCap":9871016},{"date":"2025-10-24","current":-0.799206,"twenty":-2.792029,"median":-0.713353,"eighty":-0.433434,"marketCap":8394056},{"date":"2025-10-31","current":-0.564973,"twenty":-2.792029,"median":-0.706649,"eighty":-0.433434,"marketCap":5933908},{"date":"2025-11-07","current":-0.337161,"twenty":-2.792029,"median":-0.69691,"eighty":-0.427197,"marketCap":3541203},{"date":"2025-11-14","current":-0.328049,"twenty":-2.792029,"median":-0.689273,"eighty":-0.425069,"marketCap":3445495},{"date":"2025-11-21","current":-0.276363,"twenty":-2.792029,"median":-0.685404,"eighty":-0.424413,"marketCap":3452055},{"date":"2025-11-28","current":-0.281212,"twenty":-2.792029,"median":-0.680248,"eighty":-0.421112,"marketCap":3512618},{"date":"2025-12-05","current":-0.332929,"twenty":-2.792029,"median":-0.676864,"eighty":-0.41763,"marketCap":4158616},{"date":"2025-12-12","current":-0.313535,"twenty":-2.792029,"median":-0.670095,"eighty":-0.414332,"marketCap":3916367},{"date":"2025-12-19","current":-0.275555,"twenty":-2.792029,"median":-0.667537,"eighty":-0.411688,"marketCap":3441961},{"date":"2025-12-26","current":-0.255353,"twenty":-2.792029,"median":-0.66143,"eighty":-0.410496,"marketCap":3189618},{"date":"2026-01-02","current":-0.197172,"twenty":-2.792029,"median":-0.653529,"eighty":-0.408139,"marketCap":2462870},{"date":"2026-01-09","current":-0.258586,"twenty":-2.766262,"median":-0.647886,"eighty":-0.406444,"marketCap":3229993},{"date":"2026-01-16","current":-0.268283,"twenty":-2.753006,"median":-0.645063,"eighty":-0.403633,"marketCap":3351118},{"date":"2026-01-23","current":-0.279596,"twenty":-2.716291,"median":-0.641101,"eighty":-0.401994,"marketCap":3492430},{"date":"2026-01-30","current":-0.271515,"twenty":-2.659842,"median":-0.633996,"eighty":-0.398895,"marketCap":3391493},{"date":"2026-02-06","current":-0.221414,"twenty":-2.257339,"median":-0.629483,"eighty":-0.395809,"marketCap":2765682},{"date":"2026-02-13","current":-0.208856,"twenty":-2.120789,"median":-0.623595,"eighty":-0.393618,"marketCap":2608825},{"date":"2026-02-20","current":-0.227879,"twenty":-2.102681,"median":-0.618539,"eighty":-0.392802,"marketCap":2846431},{"date":"2026-02-27","current":-0.204575,"twenty":-2.068049,"median":-0.613935,"eighty":-0.389525,"marketCap":2634717},{"date":"2026-03-06","current":-0.193026,"twenty":-2.020553,"median":-0.604665,"eighty":-0.389088,"marketCap":2485983},{"date":"2026-03-13","current":-0.214473,"twenty":-2.003335,"median":-0.596185,"eighty":-0.386476,"marketCap":2762202},{"date":"2026-03-20","current":-0.393752,"twenty":-1.956533,"median":-0.585492,"eighty":-0.385646,"marketCap":5071127},{"date":"2026-03-25","current":-0.318411,"twenty":-1.947726,"median":-0.580825,"eighty":-0.385177,"marketCap":4100813}],"updateTime":1774515992234},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARTL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622007351","title":"Artelo announces expansion opportunity for ART27.13 in muscle preservation","url":"https://stock-news.laohu8.com/highlight/detail?id=2622007351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622007351?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:40","pubTimestamp":1774471232,"startTime":"0","endTime":"0","summary":"Artelo Biosciences (ARTL) announced a strategic expansion opportunity for ART27.13 in muscle preservation for patients undergoing glucagon-like pep...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/artelo-announces-expansion-opportunity-for-art27-13-in-muscle-preservation-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/artelo-announces-expansion-opportunity-for-art27-13-in-muscle-preservation-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTL","BK4007"],"gpt_icon":0},{"id":"2622100491","title":"Artelo Biosciences initiates non-clinical study of ART27.13 for GLP-1-related muscle loss; incretin market climbs to $200 billion by 2030 forecast","url":"https://stock-news.laohu8.com/highlight/detail?id=2622100491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622100491?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:07","pubTimestamp":1774469249,"startTime":"0","endTime":"0","summary":"Artelo Biosciences initiates non-clinical study of ART27.13 for GLP-1-related muscle loss; incretin market climbs to $200 billion by 2030 forecast. Artelo announced initiation of a non-clinical study evaluating ART27.13 in models relevant to muscle preservation associated with GLP-1 receptor agonist therapy.Prior results were referenced from the Phase 2 CAReS trial in cancer anorexia and cachexia, where ART27.13 was associated with improvements in lean body mass and physical activity.The company also cited published independent peer-reviewed research describing ART27.13 as a superagonist in a kinetic multiplex assay of clinical GPCR agonists.Artelo reported filing a provisional patent application covering cannabinoid receptor agonism to prevent or mitigate muscle loss associated with GLP-1 therapy.A third-party, fully funded clinical study is planned to start in Q2 2026 to evaluate ART27.13 in glaucoma patients, and results were not reported.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL2mKwZw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","BK4585","LU2095319765.USD","NDAQ","IE00BKPKM429.USD","IE00BN0W2T93.GBP","LU0314104364.USD","LU2210150020.SGD","IE00BN0W2W23.USD","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","LU2210149790.SGD","SG9999014021.USD","SG9999014013.SGD","BK4007","SG9999014005.SGD","BK4588","IE00B3QW5Z07.USD","ARTL","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2622570004","title":"Artelo Biosciences Expands Art27.13 Development as a Potential Companion Therapy to Glp-1 Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2622570004","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622570004?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:05","pubTimestamp":1774469141,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nFWN40D18K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARTL","BK4007"],"gpt_icon":0},{"id":"2622822078","title":"Artelo Biosciences expands ART27.13 into glaucoma via fully funded investigator-sponsored clinical study; glaucoma market totals $16.3 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2622822078","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622822078?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:31","pubTimestamp":1774438297,"startTime":"0","endTime":"0","summary":"Artelo Biosciences expands ART27.13 into glaucoma via fully funded investigator-sponsored clinical study; glaucoma market totals $16.3 billion. Artelo Biosciences announced an expansion into the $16.3 billion glaucoma market through a fully funded investigator-sponsored clinical study of ART27.13, with study costs funded by Glaucoma UK and the HSC R&D Division.The company said it retains full data rights under the investigator-sponsored trial structure.Positive interim Phase 2 data for ART27.13 in cancer anorexia cachexia were already presented at the 17th International Conference on Sarcopenia, Cachexia & Wasting Disorders by Professor Barry J.A. Laird.Artelo Biosciences said ART26.12 completed a first-in-human Phase 1 single-ascending-dose study in 2025, with enrollment being prepared for a multiple ascending dose study in Q3 2026.The company said first-in-human studies for ART12.11 are planned for the first half of 2026 following UK MHRA guidance supporting streamlined Phase 1 devel","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL23yldJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","SG9999014005.SGD","LU2095319765.USD","BK4585","IE00BN0W2W23.USD","LU2210149790.SGD","BK4588","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014039.USD","BK4007","IE00BN0W2V16.EUR","LU2210150020.SGD","IE00B3QW5Z07.USD","NDAQ","IE00BGHQF748.EUR","BK4112","ARTL","IE00BN0W2T93.GBP","SG9999014013.SGD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2622901667","title":"Artelo Biosciences files to sell 4.27M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2622901667","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622901667?lang=en_us&edition=fundamental","pubTime":"2026-03-25 05:35","pubTimestamp":1774388116,"startTime":"0","endTime":"0","summary":"17:34 EDT Artelo Biosciences (ARTL) files to sell 4.27M shares of common stock for holders Published first on TheFly – the ultimate source for real...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/artelo-biosciences-files-to-sell-4-27m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/artelo-biosciences-files-to-sell-4-27m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ARTL"],"gpt_icon":0},{"id":"2622016523","title":"Artelo Biosciences Inc - May Receive up to $50 Mln in Gross Proceeds From Sales to Square Gate - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2622016523","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622016523?lang=en_us&edition=fundamental","pubTime":"2026-03-25 05:35","pubTimestamp":1774388111,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nFWN40C169:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ARTL"],"gpt_icon":0},{"id":"2621911087","title":"Artelo reports 6.38% mean weight gain in interim CAReS trial results for ART27.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2621911087","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621911087?lang=en_us&edition=fundamental","pubTime":"2026-03-24 05:26","pubTimestamp":1774301172,"startTime":"0","endTime":"0","summary":"Artelo reported interim clinical results for ART27.13, positioning the program as a potential new option for cancer-related anorexia where it says no FDA-approved treatment exists.In an interim analysis, patients receiving ART27.13 showed a mean body weight gain of 6.38% versus a -5.42% change for placebo after 12 weeks.The company also cited Phase 1 results for ART26.12 that it said support continued development toward chemotherapy-induced peripheral neuropathy, an indication it described as having no approved treatments in the U.S., UK, or EU.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artelo Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL1GYlgm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTL","BK4007"],"gpt_icon":0},{"id":"2621529587","title":"Artelo Biosciences files to sell 1.64M shares of common stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2621529587","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621529587?lang=en_us&edition=fundamental","pubTime":"2026-03-21 05:20","pubTimestamp":1774041634,"startTime":"0","endTime":"0","summary":"17:19 EDT Artelo Biosciences (ARTL) files to sell 1.64M shares of common stock Published first on TheFly – the ultimate source for real-time, marke...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/artelo-biosciences-files-to-sell-1-64m-shares-of-common-stock-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/artelo-biosciences-files-to-sell-1-64m-shares-of-common-stock-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ARTL"],"gpt_icon":0},{"id":"2620829399","title":"Artelo Biosciences Secures Bridge Financing Through Note Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2620829399","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620829399?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:14","pubTimestamp":1773872050,"startTime":"0","endTime":"0","summary":"Artelo Biosciences ( ($ARTL) ) has issued an update. On March 12, 2026, Artelo Biosciences, Inc. entered into separate securities purchase agreemen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/artelo-biosciences-secures-bridge-financing-through-note-issuance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/artelo-biosciences-secures-bridge-financing-through-note-issuance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ARTL"],"gpt_icon":0},{"id":"2620562260","title":"Artelo Biosciences issues USD 350,300 in 12% unregistered bridge notes in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620562260","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620562260?lang=en_us&edition=fundamental","pubTime":"2026-03-19 05:02","pubTimestamp":1773867733,"startTime":"0","endTime":"0","summary":"Artelo entered into securities purchase agreements with Vanquish Funding Group and Boot Capital to issue 12% bridge notes with an aggregate principal amount of USD 350,300. The notes were sold for an aggregate purchase price of USD 310,000 and include original issue discounts of USD 40,300. Shares of common stock may be issued upon conversion of the notes only following an event of default, with a conversion price at the greater of USD 0.125 and 75% of the lowest trading price over the prior 10 trading days. The securities were offered and sold in unregistered transactions under Section 4 of the Securities Act and Rule 506 of Regulation D.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artelo Biosciences Inc. published the original con","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL7382cG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ARTL"],"gpt_icon":0},{"id":"2620057265","title":"BUZZ-U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2620057265","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620057265?lang=en_us&edition=fundamental","pubTime":"2026-03-19 01:49","pubTimestamp":1773856151,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi TechnologiesWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning N","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL6N4060ZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTGX","GIS","MMED","ORA","RNXT","CTMX","BMRA","FICO","GEMI","SAIL","TTD","TE","SABS","ABBV","KNX","ARTL","SBUX","LNTH","SLG","WAL","HL","ISRG","STZ","APD","DOCU","SOFI","MTVA","NSPR","VRTX","NEM","XYZ","USEG","OVID","CDE","ARES","DUOL","CRC","LCID","ARVN","LEN"],"gpt_icon":1},{"id":"2620212265","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2620212265","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620212265?lang=en_us&edition=fundamental","pubTime":"2026-03-19 01:41","pubTimestamp":1773855666,"startTime":"0","endTime":"0","summary":"Swarmer  shares were up Wednesday after their Nasdaq debut on Tuesday through an initial public offering of 3 million shares at $5 per share.Shares jumped roughly 80% in midday trading as volume climbed to more than 17.9 million from a daily average of about 11.4 million.Artelo Biosciences  stock is up more than 33%, driven by a new, fully funded investigator-initiated study agreement to evaluate its drug candidate ART27.13 for glaucoma.Intraday trading volume surged to over 50.2 million shares from a daily average of about 33,200.VivoPower  stock was up about 23% after the company announced the termination of a $180 million F-3 registration statement. The company said alternative potential capital sources are available at project level.Intraday trading volume stood at 1.3 million shares.Price: 55.97, Change: +24.97, Percent Change: +80.56","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARTL","SWMR","VIVO","BK4198","BK4007"],"gpt_icon":1},{"id":"2620515962","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:39 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2620515962","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620515962?lang=en_us&edition=fundamental","pubTime":"2026-03-18 21:39","pubTimestamp":1773841185,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:39 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nAQN2LQO5O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTL","BK4007"],"gpt_icon":0},{"id":"2620549259","title":"BUZZ-U.S. STOCKS ON THE MOVE-Tencent, Air Products, Protagonist","url":"https://stock-news.laohu8.com/highlight/detail?id=2620549259","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620549259?lang=en_us&edition=fundamental","pubTime":"2026-03-18 21:11","pubTimestamp":1773839486,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Tencent, Air Products, ProtagonistWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL6N4060JI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAUX","NEM","SABS","BMRA","RNXT","AU","CDE","TE","01698","STZ","NBIG","NEMG","CF","FICO","PTGX","SBUX","CRC","APD","WAL","XYZ","NFXS","ARVN","HL","ARTL","NBIZ","TTD","SAIL","NEBX","SBU","CCUP","NWMX","ICRC","NFLW","SLG","OVID","MA","NFLY","MTVA","NBIL","TCHmain","NFLP","GEMG","GEMI","DOCU"],"gpt_icon":1},{"id":"2620255331","title":"Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2620255331","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620255331?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:07","pubTimestamp":1773835620,"startTime":"0","endTime":"0","summary":"Investigator-sponsored trial backed by Glaucoma UK and HSC R&D Division targets rapidly growing patient population; first enrollment expected Q2 2026BRISTOL, Tenn., March  18, 2026 (GLOBE NEWSWIRE) --","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/18/3258132/0/en/Vanderbilt-Report-Artelo-Biosciences-Expands-Into-16-3-Billion-Glaucoma-Market-With-Fully-Funded-Clinical-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTL","BK4007"],"gpt_icon":0},{"id":"2620538242","title":"BRIEF-Artelo Announces Third-Party Fully Funded Clinical Study Agreement To Evaluate Art27.13 In Glaucoma Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2620538242","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620538242?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:01","pubTimestamp":1773835260,"startTime":"0","endTime":"0","summary":"BRIEF-Artelo Announces Third-Party Fully Funded Clinical Study Agreement To Evaluate Art27.13 In Glaucoma PatientsMarch 18 (Reuters) - Artelo Biosciences Inc ARTL.O:ARTELO ANNOUNCES THIRD-PARTY FULLY ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nTUA2KP1ZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ARTL"],"gpt_icon":0},{"id":"2620906258","title":"Artelo Biosciences Shares Jump 30% Premarket After Co Plans UK Study of Glaucoma Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2620906258","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620906258?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:52","pubTimestamp":1773834769,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4N406111:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARTL","BK4007"],"gpt_icon":0},{"id":"2620995258","title":"BUZZ-Artelo Biosciences jumps as it plans UK study of glaucoma drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2620995258","media":"Reuters","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620995258?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:49","pubTimestamp":1773834551,"startTime":"0","endTime":"0","summary":"BUZZ-Artelo Biosciences jumps as it plans UK study of glaucoma drug** Shares of biotech firm Artelo Biosciences ARTL.O rise 55% to $7.35 premarket** Co says it will test experimental cannabinoid drug, ART27.13, in glaucoma, an eye disease that damages vision by raising pressure inside the eye** Says study in the UK will see if the oral capsule can safely lower eye pressure in people with glaucoma or ocular hypertension, a condition with higherthannormal eye pressure** Trial funded by Glaucoma UK and HSC R&D; patient enrolment to start in Q2 2026, co says** Drug is designed to work outside the brain to avoid “high” or mindaltering effects, co says** ART27.13 is also being tested for cancerrelated weight loss; co says glaucoma study could expand its use - ARTL** Shares down ~81% in 2025","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4N4060ZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTL","BK4007"],"gpt_icon":0},{"id":"2620587792","title":"Artelo announces third-party fully funded clinical study agreement for ART27.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2620587792","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620587792?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:45","pubTimestamp":1773834326,"startTime":"0","endTime":"0","summary":"Artelo Biosciences (ARTL) announced it has entered into a Definitive Investigator-Initiated Study Agreement with the Belfast Health and Social Care...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/artelo-announces-third-party-fully-funded-clinical-study-agreement-for-art27-13-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/artelo-announces-third-party-fully-funded-clinical-study-agreement-for-art27-13-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ARTL"],"gpt_icon":0},{"id":"2620258800","title":"Artelo Biosciences signs investigator-initiated clinical study to test ART27.13 in glaucoma patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2620258800","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620258800?lang=en_us&edition=fundamental","pubTime":"2026-03-18 19:41","pubTimestamp":1773834074,"startTime":"0","endTime":"0","summary":"Artelo said it signed an investigator-initiated study agreement with Belfast Health and Social Care Trust to evaluate ART27.13 in patients with glaucoma or ocular hypertension. The pilot trial is described as a randomized, cross-over study assessing the effects of an oral formulation of ART27.13 on intraocular pressure. Artelo will supply ART27.13 capsules as the investigational medicinal product, while the study is funded by Glaucoma UK and the HSC R&D Division. The protocol has ethics committee and MHRA approvals, and first patient enrollment is anticipated in Q2 2026. No study results have been presented yet; results will be generated in the future.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL3Jxx8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B3QW5Z07.USD","BK4585","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","NDAQ","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4588","BK4112","SG9999014039.USD","ARTL","BK4007","LU2095319765.USD","SG9999014005.SGD","SG9999014013.SGD","LU2210149790.SGD","LU0314104364.USD","LU2210150020.SGD","IE00BN0W2T93.GBP"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":91,"code":"91000000","status":"200"}]}}